Product, People, Potential

We caught up with Özgür Tuncer, CEO and Executive Director of Stablepharma, as part of ‘Product | People | Potential’. StablevaX™ made by Stablepharma, is a…

We caught up with Jenny Barnett, CEO at Monument Therapeutics where they use digital biomarkers to improve neuroscience drug development. The purpose of article series…

We caught up with Arda Ozcubukcu, Co-Founder and Director at NeuroSight, a harm reduction organisation preventing avoidable deaths and reducing drug-related harm. The purpose of…

We caught up with Isaac Johnson CEO at Verinnogen, where they are designing tools for measuring the properties of 3D surfaces for use in oncology…

We caught up we caught up with Jenny Bailey, Chief Executive Officer at Ferryx, working on the development of innovative bacterial treatments for gastrointestinal inflammatory…

We caught up with Dr. Edoardo Gaude, Co-Founder and Chief Scientific Officer at Pockit Diagnostics which is developing a tool for faster and more accurate…

We caught up with Henri Sant-Cassia, founding Director at The Conscious Fund, a global investor in early-stage ventures within psychedelic medicine, helping deliver better outcomes…

We caught up with Abi Hannah, Co-Founder & CEO at Fertility Circle, a new kind of fertility platform. The purpose of article series ‘Product |…

We caught up John Maher, Chief Scientific Officer at Leucid Bio, a UK Biotechnology company focused on progressing novel CAR T therapies to improve treatment…

We caught up Alex Latyshev, Co-Founder and CEO at HIVE, a global network of next generation mental health centres specialising in psychedelic assisted psychotherapy. The…

We caught up with Cosmo Feilding Mellen, Chief Executive Officer at Beckley Psytech Limited, a neuropharmaceutical company developing a pipeline of psychedelic compounds into licensed…

We caught up with Nikki Hawkes, Co-Founder at Stratiphy, an app for sustainable investments and personalised strategies to trade like a pro. Dan @ ADLIB:…